Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites with the Highest Rates within Race- and Ethnic-Specific Categories (Table 4.1.M1)*†
Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
Text Description
Top 10 Cancer Sites: 2011, Male, United States *†
Rates per 100,000 ‡
| All Races | White | Black | Asian/Pacific Islander § | American Indian/Alaska Native § | Hispanic §|| | |
|---|---|---|---|---|---|---|
| 1 | Prostate 128.3 |
Prostate 117.2 |
Prostate 194.7 |
Prostate 67.1 |
Prostate 62.2 |
Prostate 104.4 |
| 2 | Lung and Bronchus 73.0 |
Lung and Bronchus 72.5 |
Lung and Bronchus 87.3 |
Lung and Bronchus 45.3 |
Lung and Bronchus 47.8 |
Colon and Rectum 43.1 |
| 3 | Colon and Rectum 46.1 |
Colon and Rectum 44.9 |
Colon and Rectum 55.0 |
Colon and Rectum 38.3 |
Colon and Rectum 33.5 |
Lung and Bronchus 42.5 |
| 4 | Urinary Bladder 35.1 |
Urinary Bladder 37.1 |
Kidney and Renal Pelvis 23.2 |
Liver and Intrahepatic Bile Duct 20.0 |
Kidney and Renal Pelvis 18.2 |
Kidney and Renal Pelvis 20.0 |
| 5 | Melanomas of the Skin 25.3 |
Melanomas of the Skin 28.0 |
Urinary Bladder 19.1 |
Non-Hodgkin Lymphoma 15.3 |
Urinary Bladder 13.9 |
Urinary Bladder 19.5 |
| 6 | Non-Hodgkin Lymphoma 22.6 |
Non-Hodgkin Lymphoma 23.1 |
Liver and Intrahepatic Bile Duct 16.3 |
Urinary Bladder 14.4 |
Liver and Intrahepatic Bile Duct 12.9 |
Non-Hodgkin Lymphoma 19.3 |
| 7 | Kidney and Renal Pelvis 21.0 |
Kidney and Renal Pelvis 21.1 |
Non-Hodgkin Lymphoma 16.2 |
Stomach 14.1 |
Non-Hodgkin Lymphoma 11.6 |
Liver and Intrahepatic Bile Duct 18.8 |
| 8 | Oral Cavity and Pharynx 17.0 |
Oral Cavity and Pharynx 17.4 |
Pancreas 16.2 |
Oral Cavity and Pharynx 10.8 |
Oral Cavity and Pharynx 10.9 |
Stomach 13.2 |
| 9 | Leukemias 16.5 |
Leukemias 16.8 |
Oral Cavity and Pharynx 14.8 |
Kidney and Renal Pelvis 10.7 |
Pancreas 9.9 |
Leukemias 12.5 |
| 10 | Pancreas 13.8 |
Pancreas 13.7 |
Stomach 13.9 |
Pancreas 10.2 |
Leukemias 8.2 |
Pancreas 12.3 |
(Table 4.1.M1) Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites with the Highest Rates within Race- and Ethnic-Specific Categories
Footnotes
* Data are from selected statewide and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See registry-specific data qualityinformation. Rates cover approximately 99% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130).
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
|| Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
~ Rates are suppressed and not ranked if case counts are fewer than 16 or if the population of the specific category (race, ethnicity) is less than 50,000.
Confidence interval (CI): Range of values for a rate that will include the true value of the rate a given percentage of the time. Example: 95% CI includes the true value of the rate 95% of the time.
Notes: ONS – Other Nervous System; NOS – Not Otherwise Specified; IBD – Intrahepatic Bile Duct. Urinary bladder cases include invasive and in situ
Glossary
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014.
Comments